A randomized phase II study of cabozantinib versus weekly paclitaxel in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study
| Image |  |
|---|---|
| Description | scientific article published on 23 December 2018 |
| Author/s |
author: Ursula A. Matulonis David G Mutch Carol Aghajanian Vicky Makker |
| Publication date | December 23, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |